Ted Davis has led the OrthoRecon business for Wright Medical Technology, Inc. (“Wright”) since 2012, with global responsibility for the approximately $250 million hip and knee arthroplasty segment. Following the completion of MicroPort Scientific’s acquisition of Wright’s OrthoRecon business, Ted will continue as President of MicroPort Orthopedics Inc., which will represent MicroPort’s largest business segment. Prior to assuming leadership of the OrthoRecon business, Ted led Wright’s Corporate Development and Research & Development functions, with responsibilities for the Business Development, Government Affairs, National Accounts, Reimbursement, Medical Education and Global Research & Development teams from 2010 through 2012. Ted originally joined Wright as Vice President – Business Development in December 2006 and has led several corporate strategic initiatives, including the establishment of Wright Direct and the completion of two corporate spin-offs. Prior to joining Wright, Ted spent 10 years in the life sciences venture capital field, where he served on various boards of privately held medical device and biotechnology companies. Most recently, he was a Partner with MB Venture Partners (MBVP), a $75 million, Memphis, TN based firm focused on investments in medical technology and life sciences with a specialization in musculoskeletal diseases. Prior to joining MBVP in 2004, Ted spent seven years with Vector Fund Management (VFM), a $240 million healthcare and life sciences focused venture capital fund in Deerfield, IL. Ted began his career in the healthcare management consulting and pharmaceutical industries.
Ted received a Bachelor of Engineering degree in Biomedical Engineering from Vanderbilt University and an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University. He currently serves on the Board of Directors for SIBone, Inc. and The Memphis Research Consortium.